Sharemaestro Newsreel

RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RadNet, Inc. RDNT reported second-quarter 2026 adjusted earnings of 29 cents per share, down 14.7% year over year but ahead of the Zacks Consensus Estimate of 18 cents by 61.1%. GAAP EPS was 10 cents compared with 19 cents in the prior-year period. Growth …

Existing Home Sales Data in Focus

Pre-market futures are correcting Monday's slight selloff at this hour; ultimately, as we had said in this space yesterday, we don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning with the Consumer Price Index (CPI) Inflation Rate. …

Cardinal Health Bolts Out Of A Buy Zone Despite Mixed Earnings. Here's Why.

Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations. Continue Reading

Cardinal Health (NYSE:CAH) Issues Quarterly Earnings Results, Beats Expectations By $0.49 EPS

Why Cardinal Health Stock Is Heading for a Record After Mixed Earnings

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds. Continue Reading

Small Biz Index, Existing Home Sales & More Earnings

Tuesday, August 11th, 2026 Pre-market futures are correcting Monday's slight selloff at this hour; ultimately, as we had said in this space yesterday, we don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning with the Consumer Price …

Cardinal Health Stock Hits 52-Week High - Here's Why - Cardinal Health (NYSE:CAH)

AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth

Key Points Interested in AdaptHealth Corp.? Here are five stocks we like better. AdaptHealth is selling its roughly $600 million diabetes business to Cardinal Health and exiting certain e-commerce and drop-ship operations to simplify the company and focus on sleep, respiratory and home medical …

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Cardinal Health (CAH) reported revenue of $63.67 billion, up 5.8% over the same period last year. EPS came in at $2.91, compared to $2.08 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results

S&P 500 drug distributor Cardinal Health easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall. Rival McKesson, which whipsawed after its earnings report last week, has climbed back near a buy point. Cencora, another big S&P 500 drug distributor, also is near a …

Cardinal Health Sales Miss; Rival McKesson Near Buy Point

Cardinal Health Ticks Higher Despite Medical Wholesaler's Mixed Quarter

Cardinal Health stock rose slightly early Tuesday on better-than-expected fiscal fourth-quarter earnings, but sales missed. Continue Reading

Cardinal Health shares rise 4% as profit beats estimates and 2027 outlook tops forecasts

Cardinal Health (CAH) shares rose in pre-market trading after the company announced better-than-expected fourth-quarter earnings and provided a fiscal 2027 profit outlook that surpassed Wall Street forecasts. The company's adjusted EPS came in at $2.60, beating estimates of $2.41, and it expects double-digit EPS …

Wells Fargo raises McKesson stock price target on earnings outlook

Wells Fargo has increased its price target for McKesson Corp. (NYSE:MCK) to $933 from $812, while maintaining an Equal Weight rating, citing an improved earnings outlook. The firm also raised its adjusted earnings per share estimates for fiscal years 2027-2029, reflecting confidence in pharmaceutical …

Cardinal Health Q4 Profit Climbs, Sees Growth In FY27; Approves $5 Bln Buyback

(RTTNews) - Healthcare services company Cardinal Health, Inc., while reporting significantly higher profit in its fourth quarter on revenue strength, on Tuesday issued fiscal 2027 outlook, expecting higher adjusted earnings. Further, the Board of Directors approved a $5.0 billion increase to the share repurchase …

Cardinal Health (CAH) Q4 Earnings Beat Estimates

Cardinal Health (CAH) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.42 per share. This compares to earnings of $2.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Cardinal Health forecasts full-year profit above estimates on specialty drug strength

Cardinal Health has projected its fiscal year 2027 profit to exceed Wall Street expectations, driven by robust demand for specialty drugs, causing its shares to rise over 4% in premarket trading. The company's adjusted quarterly profit of $2.91 per share surpassed estimates, despite total …

Cardinal Health Posts Strong Fiscal 2026 Results, Boosts Outlook

Cardinal Health reported strong fiscal 2026 results, with double-digit revenue and earnings growth across all segments, aided by an IEEPA tariff refund. The company returned $1.4 billion to shareholders through buybacks, authorized an additional $5.0 billion repurchase, and provided optimistic fiscal 2027 non-GAAP EPS …

Can Cardinal Health’s Strong Earnings Guidance Offset a Mixed Quarter?

Cardinal Health (CAH) has released a full-year profit outlook that surpasses Wall Street expectations, projecting adjusted earnings of $12.40 to $12.60 per share against an anticipated $12.08. This strong guidance comes despite mixed fiscal fourth-quarter results across its various business segments. The positive earnings …

Stocks making the biggest moves premarket: Riot Platforms, Hims & Hers Health, Intel & more

Check out the companies making the biggest moves premarket: Intel – The chipmaker fell slightly after upsizing a common stock offering to $20 billion from $15 billion. The proceeds, Intel said, would be used for " general corporate purposes ." Hims & Hers Health …

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

Baird has downgraded Accendra Health (ACH) from an "Outperform" rating to "Neutral" and significantly lowered its price target from $6 to $1.50. This change in rating and price target follows other recent analyst adjustments, indicating a more cautious outlook for the company. Accendra Health …

Cardinal Health Logs Mixed Sales, Sees Growth in New Year

Cardinal Health reported mixed fiscal fourth-quarter sales but anticipates revenue growth in both of its main business segments for the new fiscal year. The company's revenue increased 6% to $63.67 billion, although it fell short of analyst expectations. Despite this, Cardinal Health's profit rose …

5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call

5 Insightful Analyst Questions From Henry Schein's Q2 Earnings Call Henry Schein delivered a positive second quarter, with results exceeding Wall Street's expectations and earning a strong market response. Management attributed the outperformance to accelerating internal sales growth, robust gains in its global dental …

Cardinal Health (NYSE:CAH) Misses Q2 CY2026 Sales Expectations

Cardinal Health (NYSE:CAH) Misses Q2 CY2026 Sales Expectations Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market's revenue expectations in Q2 CY2026, but sales rose 5.8% year on year to $63.67 billion. Its non-GAAP profit of $2.91 per share was …

Cardinal Health Q4 revenue rises 6 percent to $63.7 billion

Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating

Wells Fargo has increased its price target for McKesson (MCK) to $933 from $812, while maintaining an "Equalweight" rating on the stock. This adjustment reflects an updated outlook from the financial institution on the pharmaceutical distribution company. The article also lists other recent analyst …

Handelsbanken Fonder AB Cuts Stock Holdings in McKesson Corporation $MCK

Handelsbanken Fonder AB reduced its stake in McKesson Corporation by 13.5% in the second quarter, selling 24,987 shares and retaining 160,354 shares worth approximately $121.2 million. Despite this reduction, institutional investors collectively own a significant 85.07% of the company. McKesson has maintained a "Moderate …

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio,, Aug. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2026 to shareholders of …

Cardinal Health (CAH) secures $4.0B revolver and exits $4.0B prior facilities

Cardinal Health, Inc. (CAH) has secured a new $4.0 billion unsecured revolving credit facility with a syndicate of banks, replacing three prior facilities of the same total value. The new facility provides revolving credit access through August 7, 2031, with an option to extend …

Cardinal Health Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Fiscal Year 2027 Guidance

Cardinal Health reported strong financial results for the fourth quarter and fiscal year 2026, with revenue increases across segments and significant growth in non-GAAP diluted EPS. The company also provided optimistic guidance for fiscal year 2027, projecting 13% to 15% growth in non-GAAP EPS, …

Cencora, Inc. $COR Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB significantly reduced its holdings in Cencora, Inc. (NYSE:COR) by 32.4% in the second quarter, selling over 105,000 shares but still retaining a substantial stake. Despite this sale, Cencora demonstrated strong financial performance, exceeding earnings and revenue expectations, and announced a $2 …

KMG Fiduciary Partners LLC Cuts Holdings in Cardinal Health, Inc. $CAH

KMG Fiduciary Partners LLC reduced its stake in Cardinal Health (NYSE:CAH) by 47.4% in the second quarter, selling 24,673 shares but still retaining 27,379 shares valued at $6.5 million. Despite this reduction, institutional ownership of Cardinal Health remains high at 87.17%, with other firms …

NewEdge Advisors LLC Acquires 11,740 Shares of Cardinal Health, Inc. $CAH

NewEdge Advisors LLC increased its stake in Cardinal Health (NYSE:CAH) by 52.9% in the first quarter, purchasing an additional 11,740 shares, bringing its total holdings to 33,939 shares valued at $7.17 million. Other institutional investors also raised their positions, with hedge funds and institutions …

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results

This press release from Accendra Health reports their financial results for the second quarter of 2026. Further details on their performance would be contained within the full report.

Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $257.62, Implies 9% Upside

Cardinal Health, Inc.'s stock 12-month price target has been raised by analysts to $257.62, up from $255.6, implying a 9% potential upside from its current closing price. This revised target is based on estimates from 13 analysts, with a consensus "Buy" rating from 18 …

Baird downgrades Accendra Health stock rating on weak results

Baird downgraded Accendra Health Inc. (NYSE:ACH) from Outperform to Neutral and cut its price target due to weak results and internal issues. The firm cited unreliable guidance, impending competitive bidding, and the company's micro-cap status with an active at-the-market offering program and poison pill. …